Literature DB >> 23664660

T-cell immunity to human alphaherpesviruses.

Werner J D Ouwendijk1, Kerry J Laing, Georges M G M Verjans, David M Koelle.   

Abstract

Human alphaherpesviruses (αHHV) - herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus (VZV) - infect mucosal epithelial cells, establish a lifelong latent infection of sensory neurons, and reactivate intermittingly to cause recrudescent disease. Although chronic αHHV infections co-exist with brisk T-cell responses, T-cell immune suppression is associated with worsened recurrent infection. Induction of αHHV-specific T-cell immunity is complex and results in poly-specific CD4 and CD8 T-cell responses in peripheral blood. Specific T-cells are localized to ganglia during the chronic phase of HSV infection and to several infected areas during recurrences, and persist long after viral clearance. These recent advances hold promise in the design of new vaccine candidates.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23664660      PMCID: PMC3748210          DOI: 10.1016/j.coviro.2013.04.004

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  106 in total

1.  Different patterns of peripheral migration by memory CD4+ and CD8+ T cells.

Authors:  Thomas Gebhardt; Paul G Whitney; Ali Zaid; Laura K Mackay; Andrew G Brooks; William R Heath; Francis R Carbone; Scott N Mueller
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

2.  Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen.

Authors:  Silvia Ariotti; Joost B Beltman; Grzegorz Chodaczek; Mirjam E Hoekstra; Anna E van Beek; Raquel Gomez-Eerland; Laila Ritsma; Jacco van Rheenen; Athanasius F M Marée; Tomasz Zal; Rob J de Boer; John B A G Haanen; Ton N Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

3.  Efficacy results of a trial of a herpes simplex vaccine.

Authors:  Robert B Belshe; Peter A Leone; David I Bernstein; Anna Wald; Myron J Levin; Jack T Stapleton; Iris Gorfinkel; Rhoda L Ashley Morrow; Marian G Ewell; Abbie Stokes-Riner; Gary Dubin; Thomas C Heineman; Joann M Schulte; Carolyn D Deal
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

4.  Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens.

Authors:  J I Cohen
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

5.  Characterization of the host immune response in human Ganglia after herpes zoster.

Authors:  Kavitha Gowrishankar; Megan Steain; Anthony L Cunningham; Michael Rodriguez; Peter Blumbergs; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

6.  Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): a broad spectrum of presentations with common pseudolymphomatous aspects.

Authors:  Bernd Leinweber; Helmut Kerl; Lorenzo Cerroni
Journal:  Am J Surg Pathol       Date:  2006-01       Impact factor: 6.394

7.  A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.

Authors:  William P Halford; Ringo Püschel; Edward Gershburg; Andrew Wilber; Svetlana Gershburg; Brandon Rakowski
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

8.  CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.

Authors:  Lichen Jing; Joshua T Schiffer; Tiana M Chong; Joseph J Bruckner; D Huw Davies; Phillip L Felgner; Juergen Haas; Anna Wald; G M G M Verjans; David M Koelle
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.

Authors:  Kamal M Khanna; Robert H Bonneau; Paul R Kinchington; Robert L Hendricks
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

10.  MHC class I cross-presentation by dendritic cells counteracts viral immune evasion.

Authors:  Katrin Nopora; Caroline A Bernhard; Christine Ried; Alejandro A Castello; Kenneth M Murphy; Peggy Marconi; Ulrich Koszinowski; Thomas Brocker
Journal:  Front Immunol       Date:  2012-11-26       Impact factor: 7.561

View more
  33 in total

Review 1.  Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Authors:  Joshua T Schiffer; Sami L Gottlieb
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

2.  Herpes Simplex Virus 1 MicroRNA miR-H28 Exported to Uninfected Cells in Exosomes Restricts Cell-to-Cell Virus Spread by Inducing Gamma Interferon mRNA.

Authors:  Rongquan Huang; Jiaming Wu; Xusha Zhou; Haifang Jiang; Grace Guoying Zhou; Bernard Roizman
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 3.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

4.  A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge.

Authors:  Mayla Hsu; Meropi Aravantinou; Radhika Menon; Samantha Seidor; Daniel Goldman; Jessica Kenney; Nina Derby; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; Jose A Fernández-Romero; Thomas M Zydowsky; Melissa Robbiani
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-22       Impact factor: 2.205

5.  T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences.

Authors:  Rachel A Bender Ignacio; Meena S Ramchandani; Kerry J Laing; Christine M Johnston; David M Koelle
Journal:  Viral Immunol       Date:  2016-11-21       Impact factor: 2.257

6.  Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation.

Authors:  Insaf Salem Fourati; Anne-Julie Grenier; Élyse Jolette; Natacha Merindol; Philippe Ovetchkine; Hugo Soudeyns
Journal:  J Vis Exp       Date:  2014-07-09       Impact factor: 1.355

7.  Th1 memory differentiates recombinant from live herpes zoster vaccines.

Authors:  Myron J Levin; Miranda E Kroehl; Michael J Johnson; Andrew Hammes; Dominik Reinhold; Nancy Lang; Adriana Weinberg
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

Review 8.  Impact of sepsis on CD4 T cell immunity.

Authors:  Javier Cabrera-Perez; Stephanie A Condotta; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Leukoc Biol       Date:  2014-05-02       Impact factor: 4.962

9.  Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.

Authors:  Nicolas Çuburu; Kening Wang; Kyle N Goodman; Yuk Ying Pang; Cynthia D Thompson; Douglas R Lowy; Jeffrey I Cohen; John T Schiller
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

10.  Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination.

Authors:  Qian Qi; Mary M Cavanagh; Sabine Le Saux; Hong NamKoong; Chulwoo Kim; Emerson Turgano; Yi Liu; Chen Wang; Sally Mackey; Gary E Swan; Cornelia L Dekker; Richard A Olshen; Scott D Boyd; Cornelia M Weyand; Lu Tian; Jörg J Goronzy
Journal:  Sci Transl Med       Date:  2016-03-30       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.